A Predictive Noninvasive Single-Nucleotide Variation–Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study
A Predictive Noninvasive Single-Nucleotide Variation–Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study
Nico Seeger
1
;
Stefan Gutknecht
2
, Dr med ;
Irin Zschokke
3
, Dr med ;
Isabella Fleischmann
3
, Dr med ;
Nadja Roth
3
, Dr med ;
Jürg Metzger
3
, Prof Dr Med ;
Markus Weber
2
, Prof Dr Med ;
Stefan Breitenstein
1
, Prof Dr Med ;
Lukasz Filip Grochola
1
, PD, Dr med
1
Department of Visceral and Thoracic Surgery, Cantonal Hospital of Winterthur, Winterthur, Switzerland
2
Department of Visceral, Thoracic and Cardiovascular Surgery, Triemli Hospital, Zurich, Switzerland
3
Department of General and Visceral Surgery, Cantonal Hospital of Lucerne, Lucerne, Switzerland
Corresponding Author:
-
Lukasz Filip Grochola, PD, Dr med
-
Department of Visceral and Thoracic Surgery
-
Cantonal Hospital of Winterthur
-
Brauerstrasse 15
-
Winterthur, 8401
-
Switzerland
-
Phone:
41 52-266-41-62
-
Email: lukaszfilip.grochola@ksw.ch